Literature DB >> 2407588

Octamer transcription factors and the cell type-specificity of immunoglobulin gene expression.

I Kemler1, W Schaffner.   

Abstract

Antibodies are produced exclusively in B lymphocytes. The expression of the antibody-encoding genes, the immunoglobulin (Ig) genes, is also restricted to B cells. The octamer sequence ATGCAAAT is present in the promoter and the enhancer of Ig genes, and plays an important role in its tissue-specific expression. This sequence motif is a binding site for nuclear proteins, the so-called octamer transcription factors (Oct or OTF factors). The Oct-1 protein is present in all cell types analyzed so far, whereas Oct-2A and Oct-2B are found mainly in B lymphocytes. All three proteins show the same sequence specificity and binding affinity. It appears that the B cell-specific expression of Ig genes is mediated at least in part by cell type-specific Oct factors, and that there are both quantitative and qualitative differences between Oct-1 and Oct-2 factors. Recently, a number of other octamer factor variants were identified. Many of these may be created by alternative splicing of a primary transcript of one Oct factor gene and may serve a specific function in the fine tuning of gene expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407588     DOI: 10.1096/fasebj.4.5.2407588

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  43 in total

1.  Histone H2B gene transcription during Xenopus early development requires functional cooperation between proteins bound to the CCAAT and octamer motifs.

Authors:  C Hinkley; M Perry
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

Review 2.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

3.  Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study.

Authors:  Scott M Langevin; Devin C Koestler; Brock C Christensen; Rondi A Butler; John K Wiencke; Heather H Nelson; E Andres Houseman; Carmen J Marsit; Karl T Kelsey
Journal:  Epigenetics       Date:  2012-03       Impact factor: 4.528

4.  Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration.

Authors:  I Kemler; E Bucher; K Seipel; M M Müller-Immerglück; W Schaffner
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

5.  The transcription factor LF-A1 interacts with a bipartite recognition sequence in the promoter regions of several liver-specific genes.

Authors:  D P Ramji; M H Tadros; E M Hardon; R Cortese
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

6.  Epigenetic Interactions and Gene Expression in Peri-Implantation Mouse Embryo Development.

Authors:  Jean J Latimer; Roger A Pedersen
Journal:  Mod Cell Biol       Date:  1993

7.  Induction of the POU domain transcription factor Oct-2 during T-cell activation by cognate antigen.

Authors:  S M Kang; W Tsang; S Doll; P Scherle; H S Ko; A C Tran; M J Lenardo; L M Staudt
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

8.  Mapping the transactivation domain of the Oct-6 POU transcription factor.

Authors:  D Meijer; A Graus; G Grosveld
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

9.  Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein.

Authors:  Claire K Inman; Na Li; Paul Shore
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

10.  The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.

Authors:  M Gstaiger; O Georgiev; H van Leeuwen; P van der Vliet; W Schaffner
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.